Rezultati - Paul Frankel
- Showing 1 - 20 results of 51
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a... od Mark Kirschbaum, Kenneth A. Foon, Paul Frankel, Christopher Ruel, Bernadette Pulone, Joseph M. Tuscano, Edward M. Newman
Izdano 2013Artigo -
7
Chondroitin sulphate‐modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas‐mediated pathway... od Paul Frankel, Caroline Pellet‐Many, Pauliina Lehtolainen, Giovanna M. D’Abaco, Michelle Tickner, Lili Cheng, Ian Zachary
Izdano 2008Artigo -
8
-
9
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage... od George Somlo, Sean K. Lau, Paul Frankel, Huangpin B. Hsieh, Xiaohe Liu, Lixin Yang, Robert T. Krivacic, Richard H. Bruce
Izdano 2011Artigo -
10
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma od Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Paul Frankel, Barbara J. Gitlitz, Marianna Koczywas, Igor Espinoza‐Delgado, David R. Gandara
Izdano 2009Artigo -
11
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial od Tianhong Li, Scott Christensen, Paul Frankel, Kim Margolin, Sanjiv S. Agarwala, Thehang Luu, Philip C. Mack, Primo N. Lara, David R. Gandara
Izdano 2010Artigo -
12
Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling od Antonina Frolov, Ian Evans, Ningning Li, Kastytis Šidlauskas, Ketevan Paliashvili, Nicola Lockwood, Angela N. Barrett, Sebastian Brandner, Ian Zachary, Paul Frankel
Izdano 2016Artigo -
13
-
14
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma od Warren Chow, Paul Frankel, Chris Ruel, Dejka M. Araujo, Mohammed Milhem, Scott H. Okuno, Lee Hartner, Samir D. Undevia, Arthur P. Staddon
Izdano 2019Artigo -
15
Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial od Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel, Primo N. Lara, Christopher Ruel, Gurkamal Chatta, Elisabeth I. Heath, David I. Quinn, David R. Gandara
Izdano 2010Artigo -
16
-
17
Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation od Helen M. Jopling, Adam F. Odell, Caroline Pellet‐Many, Antony M. Latham, Paul Frankel, Asipu Sivaprasadarao, John H. Walker, Ian Zachary, Sreenivasan Ponnambalam
Izdano 2014Artigo -
18
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers od Vincent Chung, Ferdynand Kos, Nicola Hardwick, Yuan Yuan, Joseph Chao, D. Li, James Waisman, Minzhao Li, Kathryn Zurcher, Paul Frankel, Don J. Diamond
Izdano 2018Artigo -
19
A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid‐derived suppressor cells for <i>Agaricus bisporus</i>–in... od Przemyslaw Twardowski, Noriko Kanaya, Paul Frankel, Timothy W. Synold, Christopher Ruel, Sumanta K. Pal, Maribel Junqueira, Manisha Prajapati, Tina Moore, P. Tryon, Shiuan Chen
Izdano 2015Artigo -
20
Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using <sup>64</sup>Cu-DOTA-Trastuzumab PET od Joanne Mortimer, James R. Bading, David Colcher, Peter S. Conti, Paul Frankel, Mary Carroll, Shan Tong, Erasmus Poku, Joshua K. Miles, John E. Shively, Andrew Raubitschek
Izdano 2013Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Biology
Cancer
Oncology
Biochemistry
Cancer research
Gene
Chemotherapy
Gastroenterology
Cell biology
Breast cancer
Adverse effect
Clinical trial
Chemistry
Pathology
Signal transduction
Surgery
VEGF receptors
Clinical endpoint
Immunology
Vascular endothelial growth factor
Genetics
Phases of clinical research
Receptor
Tolerability
Immunotherapy
Metastatic breast cancer
Pharmacology
Histone